Print Page     Close Window     

SEC Filings

20-F
AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document
 

CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24B-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

 

[*****] INDICATES OMITTED MATERIAL THAT IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST FILED SEPARATELY WITH THE COMMISSION. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION.

 

“Payment Section ‎7.8.1
“Prosecution Section ‎8.2.1
Statement Cut-Off Date Section ‎3.2.7
Tau Patents Section ‎8.1.2
Tech Transfer Date Section ‎2.5.1
Term Section ‎12.1
Termination Notice Section ‎12.2.1
Termination Royalty Product Section 12.4.1‎(v)
Third Party Claims Section ‎11.1
Third Party Infringement Claim Section ‎‎8.4
Transferred Materials Section ‎2.5.1
Unilateral Activities Section ‎3.2.4
Unilateral Activity Cost Statement Section 3.2.7‎(i)
Unilateral Clinical Development Option Section ‎3.2.1
Unilateral Data Package Section 3.2.7‎(i)
Unilateral Data Package Trigger Section 3.2.7‎(i)
Unilateral Development Option Period Section ‎3.2.1
Unilateral Development Triggering Event Section ‎3.2.1
Unilateral Opt-In Section 3.2.7‎(ii)
VAT Section ‎7.8.2

 

 18


© AC Immune 2015